Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

May 11, 2021, 4:32 p.m. EDT

Johnson & Johnson stock outperforms competitors despite losses on the day

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Johnson & Johnson JNJ dropped 0.82% to $168.88 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.87% to 4,152.10 and Dow Jones Industrial Average DJIA falling 1.36% to 34,269.16. The stock's fall snapped a three-day winning streak. Johnson & Johnson closed $4.77 short of its 52-week high ($173.65), which the company reached on January 26th.

Despite its losses, the stock outperformed some of its competitors Tuesday, as Roche Holding AG Part. Cert. RHHVF fell 1.48% to $332.00, Merck & Co. Inc. MRK fell 0.91% to $77.46, and Pfizer Inc. PFE fell 1.28% to $39.35.true Trading volume (8.2 M) eclipsed its 50-day average volume of 7.4 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Johnson & Johnson — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.